# A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in Adolescents

> **NCT03475693** · EARLY_PHASE1 · COMPLETED · sponsor: **Corewell Health South** · enrollment: 17 (actual)

## Conditions studied

- Concussion Post Syndrome

## Interventions

- **DRUG:** Magnesium Oxide
- **DRUG:** Acetaminophen
- **DRUG:** Zofran ODT 4 MG Disintegrating Oral Tablet

## Key facts

- **NCT ID:** NCT03475693
- **Lead sponsor:** Corewell Health South
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-01
- **Primary completion:** 2019-11-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2024-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03475693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03475693, "A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in Adolescents". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03475693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*